Lataa...
Long-term outcomes in patients aged 70 years or less with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis.
BACKGROUND AND PURPOSE: We aimed to determine whether subjects aged ≤70 years who were treated with intravenous glyburide (RP-1127; BIIB093; glibenclamide) would have better long-term outcomes than those who received placebo. METHODS: Glyburide Advantage in Malignant Edema and Stroke-Remedy Pharmace...
Tallennettuna:
| Julkaisussa: | Stroke |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192530/ https://ncbi.nlm.nih.gov/pubmed/29789393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.020365 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|